A Study of RPT1G After Single and Multiple Doses in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

May 14, 2025

Study Completion Date

May 14, 2025

Conditions

Healthy

Interventions

DRUG

RPT1G

Dose formulation- Oral capsule

DRUG

Placebo

Dose formulation- Oral capsule

Trial Locations (1)

CMAX Clinical Research Pty Ltd, Adelaide

All Listed Sponsors

collaborator

Remedy Plan Australia Pty. Ltd.

INDUSTRY

lead

Remedy Plan, Inc.

INDUSTRY

NCT06667765 - A Study of RPT1G After Single and Multiple Doses in Healthy Adult Participants | Biotech Hunter | Biotech Hunter